why choose us

300×250 Ad Slot

Research Article: Prevalence of malnutrition and its prognostic impact in lung metastasis patients treated with SBRT: insights from NRI, CONUT, NRS, and PNI

Date Published: 2026-05-28

Abstract:
Malnutrition is a significant and modifiable prognostic factor in patients with pulmonary metastases undergoing stereotactic body radiotherapy (SBRT). This study evaluated and compared the prognostic utility of four nutritional assessment tools—Nutritional Risk Index (NRI), Controlling Nutritional Status (CONUT), Nutritional Risk Screening 2002 (NRS), and Prognostic Nutritional Index (PNI)—to identify malnutrition patients and inform potential interventions for improving survival. In this retrospective cohort study of 185 patients with pulmonary metastases treated with SBRT, nutritional status was assessed using the NRI, CONUT, NRS, and PNI. The primary endpoint was overall survival (OS). Statistical analyses encompassed survival analysis, subgroup exploration, correlation assessment, and development of an integrated prognostic model. Malnutrition prevalence varied: 65.95% (NRI), 63.78% (CONUT), 77.84% (NRS), and 79.46% (PNI) of patients had some nutritional impairment. Multivariable analysis identified CONUT (HR = 1.09) and NRI (HR = 3.99) as independent prognostic factors for OS. An integrated model combining nutritional (CONUT, NRI) and clinical variables showed superior predictive performance (C-index: 0.681) compared to any single tool. Malnutrition is highly prevalent and prognostic in SBRT-treated lung metastasis patients. CONUT and NRI are effective for risk stratification. The integrated model offers a superior prognostic tool, supporting the routine integration of these nutritional assessments into clinical practice to identify high-risk patients for timely intervention.

Introduction:
The development of pulmonary metastases is a common and challenging event in the natural history of many malignancies, heralding advanced disease and often complicating treatment paradigms. For selected patients with oligometastatic disease, stereotactic body radiotherapy (SBRT) has become a cornerstone of local therapy, offering high rates of tumor control and the potential to improve survival ( 1 ). SBRT delivers precise, ablative radiation doses in few fractions, which places a premium on patient tolerance and…

Read more

300×250 Ad Slot